Discover
EVMN
Evommune, Inc.
12.82
900 x undefined
500 x undefined
bid
ask
-
0.47
3.54%
700 @ 06:00 AM
13.00 +0.18 (1.40%)
| Ytd | -25.12% | |
| 1y | -36.63% |
12.65
day range
13.82
12.65
52 week range
33.20
| Open | 13.27 | Prev Close | 13.29 | Low | 12.65 | High | 13.82 | Mkt Cap | 461.76M |
| Vol | 1.60M | Avg Vol | 626.64K | EPS | -2.11 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 22.27 | 200-d Avg | 21.89 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 23.95M | ||
| Research and Development Expense | 17.32M | ||
| Selling, General and Administrative Expense | 6.64M | ||
| Operating Income | -23.95M | ||
| Net Income | -21.67M | ||
| Net Income Common Stock | -21.67M | ||
| Net Income Common Stock (USD) | -21.67M | ||
| Consolidated Income | -21.67M | ||
| Earnings per Basic Share | -0.64 | ||
| Earnings per Basic Share (USD) | -0.64 | ||
| Earnings per Diluted Share | -0.64 | ||
| Earning Before Interest & Taxes (EBIT) | -21.67M | ||
| Earning Before Interest & Taxes (USD) | -21.67M | ||
| Weighted Average Shares | 33.67M | ||
| Weighted Average Shares Diluted | 33.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 49.73M | ||
| Cash and Equivalents (USD) | 49.73M | ||
| Investments | 258.69M | ||
| Investments Current | 163.15M | ||
| Investments Non-Current | 95.55M | ||
| Current Assets | 215.86M | ||
| Property, Plant & Equipment Net | 9.57M | ||
| Total Assets | 322.46M | ||
| Debt Current | 1.25M | ||
| Total Debt | 8.55M | ||
| Current Liabilities | 10.60M | ||
| Debt Non-Current | 7.30M | ||
| Total Liabilities | 17.90M | ||
| Accumulated Retained Earnings (Deficit) | -242.76M | ||
| Shareholders Equity | 304.56M | ||
| Shareholders Equity (USD) | 304.56M | ||
| Assets Non-Current | 106.60M | ||
| Total Debt (USD) | 8.55M | ||
| Liabilities Non-Current | 7.30M | ||
| Trade and Non-Trade Payables | 4.05M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 349.00K | ||
| Net Cash Flow from Financing | 117.11M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.25M | ||
| Capital Expenditure | -83.00K | ||
| Issuance (Purchase) of Equity Shares | 117.20M | ||
| Issuance (Repayment) of Debt Securities | -87.00K | ||
| Net Cash Flow from Investing | -85.36M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -85.28M | ||
| Net Cash Flow from Operations | -27.50M | ||
| Share Based Compensation | 3.45M | ||